Results 251 to 260 of about 19,747,875 (398)

Risk factors and control of Opisthorchis viverrini in the Lower Mekong Basin: A systematic review. [PDF]

PLoS Negl Trop Dis
O'Connor SY, Mationg ML, Kelly MJ, Lowe C, Williams GM, Clements ACA, Sripa B, Sayasone S, Khieu V, Wangdi K, Stewart DE, Tangkawattana S, Suwannatrai AT, Savathdy V, Khieu V, Gannon SN, Odermatt P, Gordon CA, Wannachart S, McManus DP, Gray DJ.   +20 more
europepmc   +1 more source

Diffusion imaging in humans at 7T using readout‐segmented EPI and GRAPPA [PDF]

, 2010
Robin M. Heidemann, David A. Porter, Alfred Anwander, Thorsten Feiweier, Keith Heberlein, Thomas R. Knösche, Robert Turner   +6 more
openalex   +1 more source

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer

Molecular Oncology, EarlyView.
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui, Matthew A. Cottam, Muhammad Bilal Mirza, Keeli B. Lewis, Kristen K. Ciombor, Mary Kay Washington, Kamran Idrees   +6 more
wiley   +1 more source

In Silico Identification of Molecular Interactions of the Emerging Contaminant Octyl Methoxycinnamate (OMC) on HPT Axis: Implications for Humans and Zebrafish. [PDF]

Pharmaceuticals (Basel)
Lorigo M, Breitenfeld L, Monteiro MS, Soares AMVM, Quintaneiro C, Cairrao E.   +5 more
europepmc   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

Molecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son, Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole V. Bremer, Valentina Foglizzo, Paola Roa, Nickole Sigcha‐Coello, Yi Liao, Eric B. Haura, Alexander Drilon, John M. Koomen, Emiliano Cocco, Uwe Rix   +13 more
wiley   +1 more source

Physiological Differences Underlying Divergent Hypoxia Responses and Altitude Adaptations in Humans, Rats and Mice. [PDF]

Compr Physiol
Burtscher J, Mallet RT, Sah A, Gassmann M, Burtscher M, Iturriaga R.   +5 more
europepmc   +1 more source

The Experimental Use of Drugs in Humans [PDF]

, 1967
Zarro, Vincent J.
core   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

Molecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad, Mahmood Hachim, Tom Bertin, Karolina Penderecka, Rifat Hamoudi, Saif Khan, Rui Henrique, Natalie Bergmoser, Manit Arya, Kalle Sipila, Matteo Vietri Rudan, Asif Muneer, Aamir Ahmed   +12 more
wiley   +1 more source

Leveraging high-resolution brain imaging and (epi)genomic approaches to improve women's mental health. [PDF]

Neuropsychopharmacology
Kundakovic M, Sacher J.
europepmc   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source